| Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh F Qadri, TF Wierzba, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, ... New England Journal of Medicine 374 (18), 1723-1732, 2016 | 166 | 2016 |
| Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial F Qadri, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, YA Begum, ... The Lancet 386 (10001), 1362-1371, 2015 | 141 | 2015 |
| Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants F Qadri, MI Chowdhury, SM Faruque, MA Salam, T Ahmed, YA Begum, ... Vaccine 25 (2), 231-238, 2007 | 124 | 2007 |
| Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age A Saha, MI Chowdhury, F Khanam, MS Bhuiyan, F Chowdhury, AI Khan, ... Vaccine 29 (46), 8285-8292, 2011 | 114 | 2011 |
| Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea A Sheikh, S Shamsuzzaman, SM Ahmad, D Nasrin, S Nahar, MM Alam, ... The Journal of nutrition 140 (5), 1049-1056, 2010 | 103 | 2010 |
| Environmental variables and fisheries diversity of the Naaf River Estuary, Bangladesh MSN Chowdhury, MS Hossain, NG Das, P Barua Journal of Coastal Conservation 15, 163-180, 2011 | 101 | 2011 |
| Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh F Qadri, MI Chowdhury, SM Faruque, MA Salam, T Ahmed, YA Begum, ... The Journal of infectious diseases 192 (4), 573-579, 2005 | 91 | 2005 |
| Antigen-specific memory B-cell responses in Bangladeshi adults after one-or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally … MM Alam, MA Riyadh, K Fatema, MA Rahman, N Akhtar, T Ahmed, ... Clinical and Vaccine Immunology 18 (5), 844-850, 2011 | 90 | 2011 |
| Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo … F Qadri, M Akhtar, TR Bhuiyan, MI Chowdhury, T Ahmed, TA Rafique, ... The Lancet Infectious Diseases 20 (2), 208-219, 2020 | 89 | 2020 |
| Radioactivity in chemical fertilizers used in Bangladesh MN Alam, MI Chowdhury, M Kamal, S Ghose, H Banu, D Chakraborty Applied Radiation and Isotopes 48 (8), 1165-1168, 1997 | 81 | 1997 |
| Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial F Qadri, M Ali, J Lynch, F Chowdhury, AI Khan, TF Wierzba, JL Excler, ... The Lancet Infectious Diseases 18 (6), 666-674, 2018 | 74 | 2018 |
| Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind … F Matsuda, MI Chowdhury, A Saha, T Asahara, K Nomoto, AA Tarique, ... Vaccine 29 (10), 1855-1858, 2011 | 64 | 2011 |
| Estimation of ultimate longitudinal bending moment of ships and box girders MK Rahman, M Chowdhury Journal of ship research 40 (03), 244-257, 1996 | 60 | 1996 |
| Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind … M Akhtar, MI Chowdhury, TR Bhuiyan, J Kaim, T Ahmed, TA Rafique, ... Vaccine 37 (37), 5645-5656, 2019 | 54 | 2019 |
| Th1 and Th17 Responses to Helicobacter pylori in Bangladeshi Infants, Children and Adults TR Bhuiyan, MMT Islam, T Uddin, MI Chowdhury, A Janzon, J Adamsson, ... PloS one 9 (4), e93943, 2014 | 53 | 2014 |
| A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh F Chowdhury, AI Khan, JB Harris, RC LaRocque, MI Chowdhury, ET Ryan, ... The Pediatric infectious disease journal 27 (11), 986-992, 2008 | 50 | 2008 |
| Evaluation of a probiotics, BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in … F Matsuda, MI CHOWDHURY, A SAHA, T ASAHARA, K NOMOTO, ... Vaccine, Elsevier, Amsterdam, NL 29 (10), 2010-12, 2010 | 42 | 2010 |
| Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991–2009 MI Chowdhury, A Sheikh, F Qadri Expert review of vaccines 8 (12), 1643-1652, 2009 | 37 | 2009 |
| Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children A Saha, MI Chowdhury, M Nazim, MM Alam, T Ahmed, MB Hossain, ... Vaccine 31 (4), 647-652, 2013 | 33 | 2013 |
| The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double‐blind field trial CP Larson, D Nasrin, A Saha, MI Chowdhury, F Qadri Tropical Medicine & International Health 15 (6), 754-761, 2010 | 33 | 2010 |
